Navigation Links
Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
Date:1/11/2011

NEW YORK, Jan. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Germany Pharmaceutical Market Overview – New pricing rules set to negatively impact drug sales both domestically and internationally

http://www.reportlinker.com/p0360217/Germany-Pharmaceutical-Market-Overview-–-New-pricing-rules-set-to-negatively-impact-drug-sales-both-domestically-and-internationally.html

IntroductionThe German prescription pharmaceutical market was valued at $38.3 bn in 2009, with an annual growth rate of 4.4% between 2008 and 2009. However, future market growth will be hampered by the newly introduced price negotiation requirements in addition to raised rebates for patent protected drugs, with an impact on other countries that use Germany as a reference market.

Features and benefits

* Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in Germany* Assesses the size of the Germany pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies* Examines the Germany generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion* Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis

HighlightsLow birth rate in Germany has led to a demographic crisis prompting the need for social security reforms despite the country's swift recovery from the economic downturn. Cuts are impacting the healthcare sector with pharmaceuticals also feeling the sting. New drug price negotiation requirements will give more leverage to health insurance funds. With an expected downward pressure on price, the impact will be felt domestically as well as internationally. Generics uptake is already high and the latest cost-containment measures including tendering contracts for generics have led to downward pricing spirals, negatively impacting the domestic generics industry. Biosimilars are also gaining ground and are becoming a real threat for biologics producers.

Your key questions answered* Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in Germany* Quantify the size and growth of the prescription pharmaceutical market in Germany, analyzing key therapy areas, brands and companies* Assess drivers and resistors of generic and biosimilars uptake in Germany

To order this report:: Germany Pharmaceutical Market Overview – New pricing rules set to negatively impact drug sales both domestically and internationally

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Contact Nicolas BombourgReportlinkerEmail: nbo@reportlinker.com US: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds The Endoscopy Device Market Outlook to 2015
2. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
3. Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
4. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
5. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
6. Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth
7. Reportlinker Adds Innovative Drug Discovery in Emerging Markets
8. Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
9. Reportlinker Adds Cosmetic Surgery Products
10. Reportlinker Adds Regenerative Medicine Markets
11. Reportlinker Adds Womens Health Diagnostic Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/6/2017)... May 5, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), ... 100,000 square feet to its Welch Allyn campus. ... commitment to bring more than 100 new jobs to ... Allyn has maintained a significant presence for more than ... new positions, a large portion of which will be ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Leading CEOs from biotech, pharmaceutical, and ... 31st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/26/2017)... ... 26, 2017 , ... Somnoware, a leading provider of digital ... its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device integration ... platform, initializing devices and importing studies are just one-click operations. This plugin streamlines ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... Peace Agreements being discussed by President Donald Trump and the rest of the world. ... speed up peace talks in the continuous battle between Israel and Palestine. The world’s ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
Breaking Medicine News(10 mins):